Adropin
Adropin has been studied in 2 papers since 2021: none in people yet, 1 in animals, 1 review. The research so far is in animals. The newest paper, Dec 27, 2022: “Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation”.
2 papers study it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute of Neurological Disorders and Stroke and others
- Animals1
What did studies of Adropin find?
2Studies of Adropin measured 2 outcomes; the most studied are neurotrophic responses (1 study) and cognitive function (1).
Neurotrophic responses
upin cells1
1 study
Neurotrophic responses
upin cells1
Adropin increases neurotrophic responses in cells.
“Potent neurotrophic responses in primary cultured neurons are consistent with adropin supporting the development and function of neural networks”
Cellsprimary cultured neurons
NPJ aging and mechanisms of disease
Cognitive function
upin mice1
1 study
Cognitive function
upin mice1
Adropin improves cognitive function in mice.
“Treatment with synthetic adropin peptide also reversed age-related declines in cognitive functions”
Animalssynthetic peptide
NPJ aging and mechanisms of disease
Funding
1 grant since 2018National Institute of Neurological Disorders and StrokeUS$416.6k